Amgen Inc. (AMGN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Amgen Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Amgen Inc. (AMGN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $242.2B. It trades at $451.83, up 0.87% today, at 27.9 times earnings. Its overall quality score is 61 out of 100, ranked against the whole US market. 25 analysts' average target of $406.71 implies −10.0% from today's price. Kronos AI's 30-day forecast is −12.6% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $406.71 |
| Low – high | $230.00 – $500.00 |
| Analysts | 25 |
| Upside to average | −10.0% |
Kronos AI 30-day forecast
| Expected close | $391.47 (−12.6%) |
| Likely range | −20.1% … −11.3% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 88 |
| Solvency | 33 |
| Growth | 62 |
| Overall | 61 |
| P/E | 27.9 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator